The FWGBD Case Conversation Series will feature case-based presentations and discussion by leading experts in the areas of hematology and reproductive health on the diagnosis, treatment and management of blood disorders affecting women and girls across the lifespan. This virtual series will also offer a special emphasis on the ways in which collaboration between key specialists (i.e., hematology and reproductive health) augments management.

The principal goals of this virtual forum are to: (a) enhance participants’ understanding of the current state of knowledge; (b) utilize current cases to shape the discussion; (c) provide an overview of evidence-based, practical information as well as new, effective approaches to the diagnosis, testing, and assessment of disorders affecting women and girls; and (d) provide experience in reviewing and critiquing research. Each session will feature recent key articles to support the discussion. All registrants will receive a copy of the selected journal articles in advance.

UPCOMING EVENTS

 

Case Conversation: COVID-19 Vaccination and ITP

The development and administration of vaccines for coronavirus disease 2019 (COVID-19) was a critical to reducing the morbidity and mortality of this illness. However, as with any new therapeutic, monitoring for potential adverse events of these vaccines is important. Shortly after vaccination begun, potential cases of de novo immune thrombocytopenia (ITP) induced or exacerbated by the vaccine were reported in the U.S. Vaccine Adverse Events Reporting System (VAERS). Both healthcare providers and patients had concern regarding impact of the vaccine and its potential to lead to critical bleeding in patients with ITP. The highlighted article describes the discovery of de novo ITP cases and 3 independent series each describing outcomes of patients with preexisting ITP following SARS-CoV-2 vaccination.

In our next Case Conversation program on Tuesday, February 28th, from 12:00-1:00 p.m. ET (11:00 a.m. - 12:00 p.m. CT, 10:00 - 11:00 a.m. MT, 9:00-10:00 a.m. PT), where Dr. Hanny Al-Samkari and Dr. James Bussel will lead us through their publication, SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP. Dr. Al-Samkari will also provide more recent evidence related to COVID-19 vaccination and ITP, and Dr. Bussel will highlight evidence related to ITP treatment in adolescent females and women. The case presentation and discussion will be followed by an interactive Q&A session with participants. The production, accreditation and archiving of this program were made possible through a sponsorship from Sobi.

Learning Objectives:

  1. Discuss the data pertaining to risk ofde novo ITP following COVID-19 vaccination
  2. Discuss the data pertaining to risk of an acute exacerbation of pre-existing ITP following COVID-19 vaccination
  3. Describe the treatment and natural history of post-COVID-19 vaccine ITP and the risk of recurrent ITP exacerbation following subsequent COVID-19 vaccines in patients with exacerbation after a prior COVID-19 vaccine


Register here: https://register.gotowebinar.com/register/3296002037257296733

 


 

PREVIOUS SESSIONS 

 

Case Conversation: Iron Deficiency and Fatigue Among Adolescents with Bleeding Disorders

 1/31/23 12:00 p.m. - 1:00 p.m. ET

This is a recorded version of the webinar on Case Conversation: Iron Deficiency and Fatigue Among Adolescents with Bleeding Disorders that was presented live on January 31, 2023. This program was presented by Dr. Ayesha Zia and Dr. Sarah O’Brien.

View Program


 

Case Conversation: Safety and Efficacy of Classical Complement Pathway Inhibition with Sutimlimab in Chronic Immune Thrombocytopenia

 11/9/22 12:00 p.m. - 1:00 p.m. ET

This is a recorded version of the webinar on Case Conversation: Safety and Efficacy of Classical Complement Pathway Inhibition with Sutimlimab in Chronic Immune Thrombocytopenia that was presented live on November 9, 2022. This program was presented by Dr. Catherine Broome and was moderated by Dr. James Bussel. The production, accreditation and archiving of this program were made possible through a sponsorship from Sobi.

View Program


 

Case Conversation: An Update on Pediatric Immune Thrombocytopenia (ITP): Differentiating Primary ITP, IPD, and PID

5/24/22 12:00 p.m. - 1:00 p.m. ET

This is a recorded version of the Journal Club program Case Conversation: An Update on Pediatric Immune Thrombocytopenia (ITP): Differentiating Primary ITP, IPD, and PID. This program was presented by Dr. Michele Lambert and was moderated by Dr. Rachael Grace. The production, accreditation and archiving of this program were made possible through a sponsorship from Sobi.

View Program


Case Conversation: Sex Dimorphism in Trauma-Induced Coagulopathy

12/17/2021 12:00 p.m. - 1:00 p.m. ET

This is a recorded version of the webinar Case Conversation: Sex Dimorphism in Trauma-Induced Coagulopathy. This webinar was presented by Dr. Julia Coleman, Dr. Gene Moore, and was moderated by Dr. Kenneth Mann. It took place on December 17, 2021.

View Program 


Case Conversation: Contraceptive Use and Preferences in Females with Sickle Cell Disease

10/29/2021  12:00 p.m. - 1:00 p.m. ET

This is a recorded version of Case Conversation: Contraceptive Use and Preferences in Females with Sickle Cell Disease. This program was presented by Dr. Andrea Roe, and was moderated by Dr. Tami Chrisentery-Singleton. It took place on October 29, 2021. A copy of the recording may be obtained by contacting Kerry Funkhouser.


Case Conversation: New Developments in Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

8/25/2021  1:00 p.m. - 2:00 p.m. ET

This is a recorded version of the first Case Conversation: New Developments in Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT). This program was presented by Dr. Jim Bussel and Dr. Emilie Vander Haar, and was moderated by Dr. Andra James and Kim Roque. It took place on August 25, 2021. The production and archiving of this program were made possible in part by an educational grant from Janssen.

View Program